N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine

N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine is a synthetic small molecule belonging to the imidazo[1,5-a]pyrazine class of aromatic heterocyclic compounds. It has been studied as an inhibitor of tyrosine-protein kinase Lck (lymphocyte-specific protein tyrosine kinase), with reported in vitro activity (IC50 = 220 nM). The compound is primarily used in research settings and does not have any approved therapeutic indications or clinical trial data available. Its mechanism involves inhibition of Lck kinase activity—a target relevant to T-cell signaling pathways—but there are no known pharmaceutical products or marketed formulations containing this molecule.[1][3][7]

Other names

N-(2-Chlorophenyl)-5-phenylimidazo[1,5-a]pyrazine-8-amine